| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5588125 | Journal of Diabetes and its Complications | 2016 | 29 Pages |
Abstract
Lixisenatide treatment resulted in reductions in HbA1c and PPG levels across all SUIT quartiles. This suggests that non-insulin-related actions of lixisenatide contribute to improved glycemic control in T2D.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Daisuke Yabe, Anu Ambos, Bertrand Cariou, Lea Duvnjak, Marc Evans, Guillermo González-Gálvez, Jay Lin, Elena V. Nikonova, Pedro de Pablos-Velasco, Jean-François Yale, Bo Ahrén,